Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CD9 | P21926 | CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9) | Cancer-related genesCD markersPlasma proteins | 4 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 424 | 0.88 | |||
| CD81 | P60033 | CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81) | CD markersDisease related genesHuman disease related genes | 4 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 305 | 0.88 | |||
| LAT1 | Q01650 | Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 67 | 0.88 | |||
| CD44 | P16070 | CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44) | Blood group antigen proteinsCancer-related genesCD markers | 1 | Ovarian cancerRetinopathySolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 64 | 0.88 | ||
| CLIC4 | Q9Y696 | Chloride intracellular channel protein 4 (Glutaredoxin-like oxidoreductase CLIC4) (EC 1.8.-.-) (Intracellular chloride ion channel protein p64H1) | Predicted intracellular proteinsTransporters | 1 | Clinical-translation mediationFusion and delivery mediation | 41 | 0.88 | |||
| TSN15 | O95858 | Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15) | Predicted membrane proteinsTransporters | 4 | Fusion and delivery mediationMetabolism mediation | 32 | 0.88 | |||
| CD47 | Q08722 | Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47) | CD markersPredicted intracellular proteinsPredicted membrane proteins | 5 | Acute myeloid leukaemiaB-cell lymphomaColorectal cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 29 | 0.88 | ||
| VANG1 | Q8TAA9 | Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1) | Disease related genesHuman disease related genesPotential drug targets | 4 | Receptor-signaling mediation | 26 | 0.88 | |||
| AAAT | Q15758 | Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) | FDA approved drug targetsMetabolic proteinsPlasma proteins | 8 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 25 | 0.88 | |||
| PODXL | O00592 | Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1) | Plasma proteinsPredicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediation | 24 | 0.88 | |||
| B3A2 | P04920 | Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 10 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 23 | 0.88 | |||
| HYAS1 | Q92839 | Hyaluronan synthase 1 (EC 2.4.1.212) (Hyaluronate synthase 1) (Hyaluronic acid synthase 1) (HA synthase 1) (HuHAS1) | EnzymesMetabolic proteinsPredicted intracellular proteins | 7 | Metabolism mediation | 22 | 0.88 | |||
| CLIC5 | Q9NZA1 | Chloride intracellular channel protein 5 (Glutaredoxin-like oxidoreductase CLIC5) (EC 1.8.-.-) | 1 | Fusion and delivery mediation | 24 | 0.75 | ||||
| CSPG4 | Q6UVK1 | Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan) | Predicted membrane proteins | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 19 | 0.72 | |||
| ESYT2 | A0FGR8 | Extended synaptotagmin-2 (E-Syt2) (Chr2Syt) | Plasma proteinsPredicted membrane proteinsTransporters | 2 | Fusion and delivery mediation | 19 | 0.72 | |||
| CLD4 | O14493 | Claudin-4 (Clostridium perfringens enterotoxin receptor) (CPE-R) (CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein) | Cancer-related genesDisease related genesHuman disease related genes | 4 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 18 | 0.72 | |||
| HMOX1 | P09601 | Heme oxygenase 1 (HO-1) (EC 1.14.14.18) [Cleaved into: Heme oxygenase 1 soluble form] | Cancer-related genesDisease related genesEnzymes | 1 | Neonatal hyperbilirubinaemia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 18 | 0.72 | ||
| KCNN4 | O15554 | Intermediate conductance calcium-activated potassium channel protein 4 (SKCa 4) (SKCa4) (hSK4) (Gardos channel) (IKCa1) (hIK1) (KCa3.1) (Putative Gardos channel) (hKCa4) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Alzheimer diseaseChronic painConjunctiva disorder | Clinical-translation mediationFusion and delivery mediationImmune mediation | 17 | 0.72 | ||
| TACD2 | P09758 | Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1) | Disease related genesFDA approved drug targetsHuman disease related genes | 1 | Breast cancerNon-small-cell lung cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 16 | 0.72 | ||
| XYLT1 | Q86Y38 | Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I) | Disease related genesEnzymesHuman disease related genes | 1 | Metabolism mediation | 16 | 0.72 | |||
| EMP3 | P54852 | Epithelial membrane protein 3 (EMP-3) (Hematopoietic neural membrane protein 1) (HNMP-1) (Protein YMP) | 4 | Other mediation | 13 | 0.72 | ||||
| MFSD1 | Q9H3U5 | Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) (Smooth muscle cell-associated protein 4) (SMAP-4) | Predicted intracellular proteinsPredicted membrane proteins | 12 | Fusion and delivery mediation | 13 | 0.72 | |||
| MRP4 | O15439 | ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4) | EnzymesMetabolic proteinsPlasma proteins | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 13 | 0.72 | |||
| NRX1B | P58400 | Neurexin-1-beta (Neurexin I-beta) | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 13 | 0.72 | ||||
| EVA1B | Q9NVM1 | Protein eva-1 homolog B (Protein FAM176B) | Predicted intracellular proteins | 1 | Other mediation | 12 | 0.72 |